Yahoo Search Busca da Web

Resultado da Busca

1. www.infosalus.com › farmacia › noticia-astrazenecaAstraZeneca presenta en ASCO resultados positivos de dos ...

   www.infosalus.com › farmacia › noticia-astrazeneca

   • Em cache

   Há 13 horas · MADRID, 3 Jun. (EUROPA PRESS) - La compañía AstraZeneca ha informado sobre los resultados del ensayo fase III 'ADRIATIC', que mostraron que 'Imfinzi' (durvalumab) mejora de forma estadística y ...

2. www.marketscreener.com › quote › stockAstraZeneca: CHMP recommends approval of Tagrisso in the EU

   www.marketscreener.com › quote › stock

   • Em cache

   Há 4 horas · June 03, 2024 at 05:35 am EDT. AstraZeneca announces that Tagrisso (osimertinib), in combination with pemetrexed and platinum-based chemotherapy, has been recommended by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) for approval in the EU for the first-line treatment of adult patients with ...

3. AZN - AstraZeneca PLC

   Yahoo Finanças

   • Variação :
   • 1d
   • 5d
   • 6m
   • 1a
   • Máx.

   78.86+0.84 (+1.08%)

   em Mon, Jun 3, 2024, 9:53AM EDT - Mercado fechará em 6 h 7 min

   Preço em USD

   • Abertura 78.50
   • Alta 79.03
   • Baixa 78.38
   • Fech. ant. 78.02

   • Alt de 52 sem 79.36
   • Bai 52 sem 60.47
   • P/L 38.85
   • Cap. merc. 244.5B

   • NasdaqGS
   • •Preço em USD

4. www.fiercepharma.com › pharma › asco-astrazenecasASCO: AZ's latest Tagrisso data receive standing ovation

   www.fiercepharma.com › pharma › asco-astrazenecas

   • Em cache

   Há 13 horas · AstraZeneca’s Tagrisso just delivered an 84% improvement. | A 50% improvement on the time patients could live without disease progression would typically be considered remarkable for a new drug.

5. Vídeos

   • 

     3:12

     youtube.com

     How the AstraZeneca COVID-19 vaccine has performed so far

     27 fev.. 2021

     154.3K visualizações

   • 

     6:27

     youtube.com

     What happened with the AstraZeneca vaccine? - BBC News

     20 mar.. 2021

     336K visualizações

   • 

     1:11

     youtube.com

     Astrazeneca admits to vaccine side effects | Gravitas | WION

     29 abr.. 2024

     84.2K visualizações

   Ver tudo

6. www.boursorama.com › bourse › actualitesAstraZeneca: essai concluant dans le cancer du poumon

   www.boursorama.com › bourse › actualites

   • Em cache

   Há 13 horas · AstraZeneca: essai concluant dans le cancer du poumon. (CercleFinance.com) - AstraZeneca fait savoir que les résultats positifs d'un essai de phase III ont montré qu'Imfinzi (durvalumab ...

7. www.megabolsa.com › 2024/06/03 › bbva-astrazeneca-yAnálisis de empresas que son noticia: BBVA, AstraZeneca y Nvidia

   www.megabolsa.com › 2024/06/03 › bbva-astrazeneca-y

   • Em cache

   Há 13 horas · con quimioterapia. AstraZeneca está avanzando en el proceso de aprobación del fármaco para este tipo de cáncer. Opinión de Bankinter. Noticia positiva, implica que aumenta el número de pacientes que podrían ser tratados con Enhertu. Este fármaco está aprobado como tratamiento de segunda línea y genera ventas de 2.600M$ anuales.

8. www.morningstar.co.uk › uk › newsAstraZeneca cancer treatment Tagrisso recommended ...

   www.morningstar.co.uk › uk › news

   • Em cache

   Há 13 horas · AstraZeneca's cancer fighting treatment reduced instances of disease progression or death by 84% in the double-blind, placebo-controlled trial involving 216 patients across 15 countries.

9. mfn.se › cis › aMFN.se > AstraZeneca > AstraZeneca: Tagrisso with the ...

   mfn.se › cis › a

   • Em cache

   Há 13 horas · AstraZeneca's Tagrisso (osimertinib) with the addition of pemetrexed and platinum-based chemotherapy has been recommended for approval in the European Union (EU) for 1st-line treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) whose tumours have exon 19 deletions or exon 21 (L858R) mutations.